XML 211 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Income Per Share and Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share And Stockholders Equity [Abstract] |
Income Per Share and Stockholders' Equity | Income Per Share and Stockholders’ Equity The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in millions, except share and per share data):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Basic Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 363 |  |  | $ | 225 |  |  | $ | 741 |  |  | $ | 481 |
Weighted average shares outstanding for basic income per share | 297,557,891 |  |  | 306,253,811 |  |  | 298,589,340 |  |  | 306,269,264 |
Basic income per share attributable to CBRE Group, Inc. stockholders | $ | 1.22 |  |  | $ | 0.73 |  |  | $ | 2.48 |  |  | $ | 1.57 |
Diluted Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 363 |  |  | $ | 225 |  |  | $ | 741 |  |  | $ | 481 |
Weighted average shares outstanding for basic income per share | 297,557,891 |  |  | 306,253,811 |  |  | 298,589,340 |  |  | 306,269,264 |
Dilutive effect of contingently issuable shares | 2,699,439 |  |  | 2,051,202 |  |  | 2,461,001 |  |  | 2,011,847 |
Weighted average shares outstanding for diluted income per share | 300,257,330 |  |  | 308,305,013 |  |  | 301,050,341 |  |  | 308,281,111 |
Diluted income per share attributable to CBRE Group, Inc. stockholders | $ | 1.21 |  |  | $ | 0.73 |  |  | $ | 2.46 |  |  | $ | 1.56 |
No shares were excluded from the computation of diluted income per share for the three months ended September 30, 2025. For the nine months ended September 30, 2025, 331,034 of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. For the three and nine months ended September 30, 2024, 5,875 and 238,815, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. On November 21, 2024, our board of directors authorized an additional $5.0 billion to our existing $4.0 billion share repurchase program (as amended, the 2024 program) bringing the total authorized amount under the 2024 program to a total of $9.0 billion as of September 30, 2025. The board also extended the term of the 2024 program through December 31, 2029. We did not repurchase any shares of our common stock during the three months ended September 30, 2025 under the 2024 program. During the nine months ended September 30, 2025, we repurchased 5,185,163 shares of our common stock with an average price of $127.82 per share for an aggregate of $663 million under the 2024 program. As of September 30, 2025, we had approximately $5.2 billion of capacity remaining under the 2024 program. During the three months ended September 30, 2024, we repurchased 567,209 shares of our common stock with an average price of $109.20 per share for an aggregate of $62 million under the 2024 program. During the nine months ended September 30, 2024, we repurchased 1,121,950 shares of our common stock with an average price of $98.35 per share for an aggregate of $110 million under the 2024 program.

X
- Definition Earnings per share and stockholders' equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityAbstract
Namespace Prefix: | cbre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings per share and stockholder's equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityTextBlock
Namespace Prefix: | cbre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration